Therefore, deletion of PTPN2 often leads to the development of inflammation-related diseases such as Crohn’s disease, hepatitis, diabetes, and atherosclerosis (Spalinger et al., 2020; Sabev et al., 2021; Zhu et al., 2021). Here, PTPN2 is linked to atherosclerosis.